<!DOCTYPE html><html><head><title>Primary open-angle glaucoma (POAG): percentage of patients aged 18 years and older with a diagnosis of POAG or their caregiver who were counseled within 12 months about 1) the potential impact of glaucoma on their visual functioning and quality of life, and 2) the importance of treatment adherence.</title><link rel="stylesheet" type="text/css" href="style.css"></head><body><div class='section'>
<h2>General
</h2>
<div class='field field_text'>
<h3>
Title
</h3>
<div class='FieldValue'>
<div class="content_title">Primary open-angle glaucoma (POAG): percentage of patients aged 18 years and older with a diagnosis of POAG or their caregiver who were counseled within 12 months about 1) the potential impact of glaucoma on their visual functioning and quality of life, and 2) the importance of treatment adherence.</div>
</div>

</div>
<div class='field field_citation'>
<h3>
Source(s)
</h3>
<div class='FieldValue'>
<table><tr><td>American Academy of Ophthalmology (AAO). Eye care quality measure: primary open-angle glaucoma: counseling on glaucoma. San Francisco (CA): American Academy of Ophthalmology (AAO); 2015 Jan. 5 p. </td></tr></table>
</div>

</div>

</div>
<div class='section'>
<h2>Measure Domain
</h2>
<div class='field field_picklist-one'>
<h3>
Primary Measure Domain
</h3>
<div class='FieldValue'>
Clinical Quality Measures: Process
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Secondary Measure Domain
</h3>
<div class='FieldValue'>
Does not apply to this measure
</div>

</div>

</div>
<div class='section'>
<h2>Brief Abstract
</h2>
<div class='field field_text'>
<h3>
Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This measure is used to assess the percentage of patients aged 18 years and older with a diagnosis of primary open-angle glaucoma (POAG) or their caregiver who were counseled within 12 months about 1) the potential impact of glaucoma on their visual functioning and quality of life, and 2) the importance of treatment adherence.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Rationale
</h3>
<div class='FieldValue'>
<ol style="list-style-type: decimal;">
    <li>Scientific basis for assessing counseling in disease impact and adherence
    <p>Disease management is a challenge for the patient and the ophthalmologist or optometrist because primary open-angle glaucoma (POAG) is a chronic, frequently asymptomatic condition that may require daily use of multiple and expensive medications (Fiscella et al., 2003) with potential side effects, or may require laser or incisional surgery. Establishing a regimen requires attention to its effectiveness (potential impact on the disease) and toxicity (the drug-induced side effects), and the degree to which efficacy is reduced by nonadherence to therapy due to visual, physical, social, economic, or psychologic factors. The ophthalmologist should consider these issues in choosing a regimen of maximal effectiveness and tolerance to achieve the desired therapeutic response for each patient (American Academy of Ophthalmology [AAO], 2010).</p>
    <p>Patient education and informed participation in treatment decisions may improve adherence and overall effectiveness of glaucoma management (Haynes et al., 2003; Kass et al., 1987; Kass et al., 1986; Osterberg &amp; Blaschke, 2005; Zimmerman et al., 1984).&nbsp;Repeated instruction in proper techniques for using medication may improve adherence to therapy (see above). A study described that greater physician awareness of adherence is necessary to help the patient become adherent (Gelb et al., 2008).&nbsp;More directly, patients with visual field loss in even one eye have noticeable decrements in not only vision related functioning but also visual functioning scores (McKean-Cowdin et al., 2007), yet, ophthalmologists and optometrists do not routinely inquire about this (Fremont et al., 2003). Information gained from asking about this issue of quality of life will increase provider awareness of the impact of the disease in that patient and likely lead to greater intensity of treatment in lowering intraocular pressure (IOP), thereby improving patient outcomes as reported in numerous randomized controlled trials (RCTs).</p>
    </li>
    <li>Evidence of gap in care
    <p>Published studies indicate that nearly half of patients with POAG fear blindness and visual loss upon diagnosis with glaucoma (Janz et al., 2007), yet physicians inquire about the patient's visual functioning and quality of life less than 1% of the time (Fremont et al., 2003).</p>
    <p>As to adherence and compliance, as noted in the guidelines section above, patient adherence and compliance to therapy are no better in glaucoma than in other chronic diseases, suggesting that most patients are not fully compliant or adherent to their use of medications. In addition, several studies indicate that half of patients with POAG in the Medicare population will have at least one 18 month gap in their continuous care over a 5 year time period (Lee et al., 2003), supporting the findings of several single site studies indicating that many patients have failed to keep scheduled appointments.</p>
    </li>
</ol>
<p class="Note">The following clinical recommendation statements are quoted <span style="text-decoration: underline;">verbatim</span> from the referenced clinical guidelines (from the AAO) and represent the evidence base for the measure:</p>
<p class="Note">The diagnosis, severity of the disease, prognosis and management plan, and likelihood of long-term therapy should be discussed with the patient (AAO, 2010). </p>
<p class="Note">Adherence to the therapeutic regimen and the patient's response to recommendations for therapeutic alternatives or diagnostic procedures should be discussed (AAO, 2010). </p>
<p class="Note">Patients should be encouraged to alert their ophthalmologists to physical or emotional changes that occur when taking glaucoma medications (AAO, 2010). Glaucoma treatments frequently affect patients' quality of life, including employment issues (e.g., fear of loss of job and insurance from diminished ability to read and drive), social issues (e.g., fear of negative impact on relationships and sexuality), and loss of independence and activities that require good visual acuity (e.g., sports and other hobbies). The ophthalmologist should be sensitive to these problems and provide support and encouragement. Some patients may find peer support groups or counseling helpful. </p>
<p class="Note">Adequate treatment of glaucoma requires a high level of adherence to therapy. Frequently this is not achieved; studies indicate relatively poor adherence to therapy in one-third or more of patients, depending on the medications used (Kass et al., 1987). Repeated instruction in proper techniques for using medication may improve adherence to therapy (Kass et al., 1986; Zimmerman et al., 1984; Haynes et al., 2003; Osterberg &amp; Blaschke, 2005). At each examination, medication dosage and frequency of use should be recorded (AAO, 2010). Adherence to the therapeutic regimen and the patient&rsquo;s response to recommendations for therapeutic alternatives or diagnostic procedures should be discussed (AAO, 2010). Cost may be a factor in adherence, especially when multiple medications are used (Fiscella et al., 2003). </p>
</div>

</div>
<div class='field field_citation'>
<h3>
Evidence for Rationale
</h3>
<div class='FieldValue'>
<table><tr><td>American Academy of Ophthalmology (AAO). Eye care quality measure: primary open-angle glaucoma: counseling on glaucoma. San Francisco (CA): American Academy of Ophthalmology (AAO); 2015 Jan. 5 p. </td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>American Academy of Ophthalmology (AAO). Preferred practice patterns. Primary open-angle glaucoma. San Francisco (CA): American Academy of Ophthalmology (AAO); 2010. </td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Fiscella RG, Green A, Patuszynski DH, Wilensky J. Medical therapy cost considerations for glaucoma. Am J Ophthalmol. 2003 Jul;136(1):18-25. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12834665" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Fremont AM, Lee PP, Mangione CM, Kapur K, Adams JL, Wickstrom SL, Escarce JJ. Patterns of care for open-angle glaucoma in managed care. Arch Ophthalmol. 2003 Jun;121(6):777-83. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12796247" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Gelb L, Friedman DS, Quigley HA, Lyon DW, Tan J, Kim EE, Zimmerman TJ, Hahn SR. Physician beliefs and behaviors related to glaucoma treatment adherence: the Glaucoma Adherence and Persistency Study. J Glaucoma. 2008 Dec;17(8):690-8.</td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Haynes R, McDonald H, Garg A, Montague P. Interventions for helping patients to follow prescriptions for medications (Cochrane Review). Chichester: John Wiley & Sons, Ltd.; 2003. 48 p. </td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Janz NK, Wren PA, Guire KE, Musch DC, Gillespie BW, Lichter PR, Collaborative Initial Glaucoma Treatment Study. Fear of blindness in the Collaborative Initial Glaucoma Treatment Study: patterns and correlates over time. Ophthalmology. 2007 Dec;114(12):2213-20. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=17490746" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Kass MA, Gordon M, Morley RE Jr, Meltzer DW, Goldberg JJ. Compliance with topical timolol treatment. Am J Ophthalmol. 1987 Feb 15;103(2):188-93. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=3812621" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Kass MA, Meltzer DW, Gordon M, Cooper D, Goldberg J. Compliance with topical pilocarpine treatment. Am J Ophthalmol. 1986 May 15;101(5):515-23. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=3706455" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Lee PP, Feldman ZW, Ostermann J, Brown DS, Sloan FA. Longitudinal rates of annual eye examinations of persons with diabetes and chronic eye diseases. Ophthalmology. 2003 Oct;110(10):1952-9.</td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>McKean-Cowdin R, Varma R, Wu J, Hays RD, Azen SP, Los Angeles Latino Eye Study Group. Severity of visual field loss and health-related quality of life. Am J Ophthalmol. 2007 Jun;143(6):1013-23. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=17399676" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005 Aug 4;353(5):487-97. [127 references] <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16079372" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Zimmerman TJ, Kooner KS, Kandarakis AS, Ziegler LP. Improving the therapeutic index of topically applied ocular drugs. Arch Ophthalmol. 1984 Apr;102(4):551-3. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=6704011" target="_blank">PubMed</a></td></tr></table>
</div>

</div>
<div class='field field_text'>
<h3>
Primary Health Components
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Primary open-angle glaucoma (POAG); patient/caregiver counseling; visual functioning; quality of life; treatment adherence</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Denominator Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>All patients aged 18 years and older with a diagnosis of primary open-angle glaucoma (POAG) (see the related "Denominator Inclusions/Exclusions" field)</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Numerator Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Patients or their caregiver(s) who were counseled within 12 months about 1) the potential impact of glaucoma on their visual functioning and quality of life and 2) the importance of treatment adherence</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Evidence Supporting the Measure
</h2>
<div class='field field_picklist-choice'>
<h3>
Type of Evidence Supporting the Criterion of Quality for the Measure
</h3>
<div class='FieldValue'>
A clinical practice guideline or other peer-reviewed synthesis of the clinical research evidence
</div>
<div class='FieldValue'>
A systematic review of the clinical research literature (e.g., Cochrane Review)
</div>
<div class='FieldValue'>
One or more research studies published in a National Library of Medicine (NLM) indexed, peer-reviewed journal
</div>

</div>
<div class='field field_text'>
<h3>
Additional Information Supporting Need for the Measure
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Extent of Measure Testing
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>State of Use of the Measure
</h2>
<div class='field field_picklist-one'>
<h3>
State of Use
</h3>
<div class='FieldValue'>
Current routine use
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Current Use
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>

</div>
<div class='section'>
<h2>Application of the Measure in its Current Use
</h2>
<div class='field field_picklist-choice'>
<h3>
Measurement Setting
</h3>
<div class='FieldValue'>
Ambulatory/Office-based Care
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Professionals Involved in Delivery of Health Services
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Least Aggregated Level of Services Delivery Addressed
</h3>
<div class='FieldValue'>
Individual Clinicians or Public Health Professionals
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Statement of Acceptable Minimum Sample Size
</h3>
<div class='FieldValue'>
Unspecified
</div>

</div>
<div class='field field_text'>
<h3>
Target Population Age
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Age greater than or equal to 18 years</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Target Population Gender
</h3>
<div class='FieldValue'>
Either male or female
</div>

</div>

</div>
<div class='section'>
<h2>National Strategy for Quality Improvement in Health Care
</h2>
<div class='field field_text'>
<h3>
National Quality Strategy Aim
</h3>
<div class='FieldValue'>
<ul><li>Better Care</li></ul>
</div>

</div>
<div class='field field_text'>
<h3>
National Quality Strategy Priority
</h3>
<div class='FieldValue'>
<ul><li>Person- and Family-centered Care</li><li>Prevention and Treatment of Leading Causes of Mortality</li></ul>
</div>

</div>

</div>
<div class='section'>
<h2>Institute of Medicine (IOM) National Health Care Quality Report Categories
</h2>
<div class='field field_picklist-choice'>
<h3>
IOM Care Need
</h3>
<div class='FieldValue'>
Living with Illness
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
IOM Domain
</h3>
<div class='FieldValue'>
Effectiveness
</div>
<div class='FieldValue'>
Patient-centeredness
</div>

</div>

</div>
<div class='section'>
<h2>Data Collection for the Measure
</h2>
<div class='field field_text'>
<h3>
Case Finding Period
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Denominator Sampling Frame
</h3>
<div class='FieldValue'>
Patients associated with provider
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
Denominator (Index) Event or Characteristic
</h3>
<div class='FieldValue'>
Clinical Condition
</div>
<div class='FieldValue'>
Patient/Individual (Consumer) Characteristic
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Denominator Time Window
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_text'>
<h3>
Denominator Inclusions/Exclusions
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Inclusions</strong><br />
All patients aged 18 years and older with a diagnosis of primary open-angle glaucoma (POAG)</p>
<p><strong>Exclusions</strong><br />
Documentation of medical reason(s) for not providing counseling to the patient or caregiver (e.g., patient has impaired mental status and no caregiver) </p>
<p class="Note"><strong>Note</strong>: Refer to the original measure documentation for International Classification of Diseases, Ninth Revision (ICD-9), ICD-10, and Current Procedural Terminology (CPT) codes.</p></div>
</div>

</div>
<div class='field field_picklist-choice-4'>
<h3>
Exclusions/Exceptions
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_text'>
<h3>
Numerator Inclusions/Exclusions
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Inclusions</strong><br />
Patients or their caregiver(s) who were counseled within 12 months about 1) the potential impact of glaucoma on their visual functioning and quality of life and 2) the importance of treatment adherence</p>
<p class="Note"><strong>Note</strong>: Refer to the original measure documentation for Current Procedural Terminology (CPT) codes.</p>
<p><strong>Exclusions</strong><br />
Unspecified</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Numerator Search Strategy
</h3>
<div class='FieldValue'>
Fixed time period or point in time
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Data Source
</h3>
<div class='FieldValue'>
Administrative clinical data
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Type of Health State
</h3>
<div class='FieldValue'>
Does not apply to this measure
</div>

</div>
<div class='field field_text'>
<h3>
Instruments Used and/or Associated with the Measure
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Computation of the Measure
</h2>
<div class='field field_picklist-one'>
<h3>
Measure Specifies Disaggregation
</h3>
<div class='FieldValue'>
Does not apply to this measure
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Scoring
</h3>
<div class='FieldValue'>
Rate/Proportion
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Interpretation of Score
</h3>
<div class='FieldValue'>
Desired value is a higher score
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Allowance for Patient or Population Factors
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Standard of Comparison
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>

</div>
<div class='section'>
<h2>Identifying Information
</h2>
<div class='field field_text'>
<h3>
Original Title
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Primary open-angle glaucoma: counseling on glaucoma.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Measure Collection Name
</h3>
<div class='FieldValue'>
Eye Care Quality Measures
</div>

</div>
<div class='field field_orglist'>
<h3>
Submitter
</h3>
<div class='FieldValue'>
American Academy of Ophthalmology - Medical Specialty Society
</div>

</div>
<div class='field field_orglist-p'>
<h3>
Developer
</h3>
<div class='FieldValue'>
American Academy of Ophthalmology - Medical Specialty Society
</div>

</div>
<div class='field field_text'>
<h3>
Funding Source(s)
</h3>
<div class='FieldValue'>
<div class="content_para"><p>American Academy of Ophthalmology (AAO)</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Composition of the Group that Developed the Measure
</h3>
<div class='FieldValue'>
<ul style="list-style-type: disc;">
    <li>Paul P. Lee, MD, JD (<em>Co-Chair</em>) </li>
    <li>Jinnet B. Fowles, PhD (<em>Co-Chair</em>) </li>
    <li>Richard L. Abbott, MD </li>
    <li>Jeffrey S. Karlik, MD </li>
    <li>Lloyd P. Aiello, MD PhD </li>
    <li>Mathew W. MacCumber, MD, PhD </li>
    <li>Priscilla P. Arnold, MD </li>
    <li>Mildred M. G. Olivier, MD </li>
    <li>Richard Hellman, MD, FACP, FACE </li>
    <li>James L. Rosenzweig, MD, FACE </li>
    <li>Leon W. Herndon, MD </li>
    <li>Sam J. W. Romeo, MD, MBA </li>
    <li>Kenneth J. Hoffer, MD </li>
    <li>John T. Thompson, MD </li>
</ul>
</div>

</div>
<div class='field field_text'>
<h3>
Financial Disclosures/Other Potential Conflicts of Interest
</h3>
<div class='FieldValue'>
<div class="content_para"><p>None</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Adaptation
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This measure was not adapted from another source.</p></div>
</div>

</div>
<div class='field field_date'>
<h3>
Date of Most Current Version in NQMC
</h3>
<div class='FieldValue'>
2015 Jan
</div>

</div>
<div class='field field_text'>
<h3>
Measure Maintenance
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Reviewed and updated if appropriate on an annual cycle</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Date of Next Anticipated Revision
</h3>
<div class='FieldValue'>
<div class="content_para"><p>2016</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Measure Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This is the current release of the measure.</p>
<p>This measure updates a previous version: American Academy of Ophthalmology, Physician Consortium for Performance Improvement&reg;, National Committee for Quality Assurance. Eye care physician performance measurement set. Chicago (IL): American Medical Association (AMA); 2010 Sep. 35 p.</p>
<p>The measure developer reaffirmed the currency of this measure in December 2015. </p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Measure Availability
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Source not available electronically.</p>
<p>For more information, contact the American Academy of Ophthalmology (AAO) at 655 Beach Street, San Francisco, CA 94109; Phone: 415-561-8500; Fax: 415-561-8533; Web site: <a href="http://www.aao.org" title="AAO Web site">www.aao.org</a>.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
NQMC Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This NQMC summary was completed by ECRI Institute on February 13, 2008. The information was verified by the measure developer on April 22, 2008. </p>
<p>This NQMC summary was retrofitted into the new template on May 19, 2011. </p>
<p>This NQMC summary was updated by ECRI Institute on July 2, 2015. The information was verified by the measure developer on July 13, 2015. </p>
<p>The information was reaffirmed by the measure developer on December 16, 2015. </p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Copyright Statement
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This NQMC summary is based on the original measure, which is subject to the measure developer's copyright restrictions.</p>
<p>For more information, contact Debra Marchi at the American Academy of Ophthalmology (AAO), <a href="mailto:dmarchi@aao.org">dmarchi@aao.org</a>, regarding use and reproduction of these measures.</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Production
</h2>
<div class='field field_citation'>
<h3>
Source(s)
</h3>
<div class='FieldValue'>
<table><tr><td>American Academy of Ophthalmology (AAO). Eye care quality measure: primary open-angle glaucoma: counseling on glaucoma. San Francisco (CA): American Academy of Ophthalmology (AAO); 2015 Jan. 5 p. </td></tr></table>
</div>

</div>

</div>
<div class='section'>
<h2>Disclaimer
</h2>
<div class='field field_text'>
<h3>
NQMC Disclaimer
</h3>
<div class='FieldValue'>
<p>The National Quality Measures Clearinghouse™ (NQMC) does not develop, produce, approve, or endorse the measures represented on this site.</p> 
<p>All measures summarized by NQMC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public and private organizations, other government agencies, health care organizations or plans, individuals, and similar entities.</p> 
<p>Measures represented on the NQMC Web site are submitted by measure developers, and are screened solely to determine that they meet the <a href="/help-and-about/summaries/inclusion-criteria">NQMC Inclusion Criteria</a>.</p> 
<p>NQMC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or its reliability and/or validity of the quality measures and related materials represented on this site. Moreover, the views and opinions of developers or authors of measures represented on this site do not necessarily state or reflect those of NQMC, AHRQ, or its contractor, ECRI Institute, and inclusion or hosting of measures in NQMC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding measure content are directed to contact the measure developer.</p>
</div>

</div>

</div>
</body></html>